Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
PMID: 32987701
Research status SLU-PP-332 is not FDA approved, has no established human dosage, and lacks a defined human safety profile
Curr Issues Mol Biol 37:120
In particular, section 1833(t)(16)(G) provides that with respect to a non-opioid treatment for pain relief furnished on or after January 1, 2025, ( and before January 1, 2028, the Secretary shall not package payment for the non-opioid treatment for pain relief into payment for a covered OPD service (or group of services) and shall make an additional payment for the non-opioid treatment for pain relief as specified in clause (ii) of that section
Fuster V, Ryden LE, Cannom DS, et al
Also see our Top Picks for Boswellia and other joint health supplements
US$ 29.23
US$ 28.62
US$ 22.31
US$ 27.36
US$ 23.44
US$ 24.87
